Itonic (NASDAQ:ITOC) Issues Earnings Results

Itonic (NASDAQ:ITOC) announced its quarterly earnings data on Wednesday. The company reported ($0.05) earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of $0.05 million during the quarter.

Itonic Trading Up 4.5%

ITOC traded up $0.01 during trading on Wednesday, reaching $0.28. The company’s stock had a trading volume of 72,353 shares, compared to its average volume of 2,059,469. The firm has a fifty day simple moving average of $0.29 and a two-hundred day simple moving average of $0.31. Itonic has a 1 year low of $0.22 and a 1 year high of $1.15.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.